"Freyr Solutions announced that Gens & Associates covered its RIM solution capabilities in their industry standard 2022 World Class RIM Research.

The survey is part of Gens & Associates’ sixth successive RIM study since 2013 and the 38th Regulatory study since 2007. For 2022, 45 companies were part of the final study design, with 76 participants representing a broad diversity of company size, headquarters location, and product portfolio type. Rooting to the whitepaper published by G&A, 15 base capabilities (including system, process, and organizational) that support Regulatory activities were considered during the survey.

Referring to Freyr in their ‘Analyst Notes for RIM Providers,’ G&A mentioned, “Freyr has been a provider of services in life sciences for over ten (10) years, and in recent years has brought that experience into the software space: first in Publishing, and more recently in Registration Management/RIM, Labeling & Artwork, and Regulatory Intelligence. We have recently begun to follow them and have been impressed by what we’ve seen, especially in Label Management software and services. Of particular interest to us is their impressive entry into the Regulatory Intelligence space with both software and data services, which is already being implemented with a top pharma. Over the past year, they added quite a few new customers across all their capabilities and enjoyed full retention of existing customers.

Over the next 18 months, Freyr plans enhancements to its publishing capability, including establishing eCTD 4.0 readiness, Medical Devices templates for US and EU submissions, and a collaborative submission review process. They also plan to establish automation for the management of HA correspondence and responses, as well as continue to mature registration management capabilities and establish integrated regulatory intelligence within their RIM system. We are very interested to see how Freyr evolves over the next couple of years.”

Upon being listed in the survey report of the G&A 2022 RIM study, Rajiv Rangan, Co-CEO, Freyr, quoted, “This mention of Freyr’s RIM solutions in the 2022 World Class RIM Survey is an important reinforcement of our RIM strategy and the accelerated growth we are experiencing in this space.”

Click here to learn more about how Freyr is destined for digital transformation in life sciences.

About Gens & Associates
Gens & Associates is a boutique Life Science benchmarking and advisory firm specializing in performance improvement, strategy, industry benchmarking, World Class RIM℠, and organizational transition. Their primary focus is the Regulatory domain and how it connects and collaborates with clinical, commercial, safety, quality, and health authorities. Their mission is “Everybody Gets Better” by helping all stakeholders in the regulatory eco-system accelerate global transformation, increase efficiency and organizational agility to shorten approvals of effective new drugs, and contribute to medicine affordability.

Click here to find out more about Gens & Associates and their world-class RIM research."